This podcast features:
Moderator: Eric S. Langer, managing partner at BioPlan Associates, Inc.

Panelists

Chris Forespring, senior manager of downstream production at Medimmune/Astra Zeneca

Francis Torres, principal in bioprocess manufacturing and technology at Merck

Paul Jorjorian, senior scientific manager for purification at Gallus BioPharmaceuticals

Duncan Low, executive scientific director at Amgen

This podcast was recorded at the 2014 BioProcess Theater which took place at the 2014 BIO International Convention, June 23-26, 2014. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2014 BioProcess Theater consisted of five main presentation tracks: Antibody-Drug Conjugates, Single-Use Processing, Upstream Processing, Manufacturing, and Cell Therapies.

If you would like more information on these presentations, please email us: info@bioprocessintl.com